First COVID-19 vaccine tested in the US
In Seattle the first phase of clinical trials for a potential Coronavirus vaccine has begun. 4 out of 45 participants have received their first dose of the experimental vaccine. The vaccine was developed through a partnership between the US National Institute of Allergy and Infectious Diseases (NIAID) and Moderna, a biotechnology company based in Cambridge, Massachusetts.
Image via Unsplash/CDC